$ICUI
ICU Medical Inc

2013 Q4 Form 10-Q Financial Statement

#000088398413000048 Filed on October 22, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $77.94M $82.82M $81.41M
YoY Change -5.72% 1.73% 6.47%
Cost Of Revenue $39.00M $41.86M $40.71M
YoY Change -4.65% 2.82% -0.43%
Gross Profit $38.95M $40.96M $40.70M
YoY Change -6.76% 0.64% 14.4%
Gross Profit Margin 49.97% 49.45% 49.99%
Selling, General & Admin $20.60M $22.40M $20.18M
YoY Change -0.48% 11.01% -1.15%
% of Gross Profit 52.9% 54.69% 49.58%
Research & Development $3.500M $3.140M $2.988M
YoY Change 59.09% 5.09% 59.19%
% of Gross Profit 8.99% 7.67% 7.34%
Depreciation & Amortization $5.000M $4.900M $4.800M
YoY Change 6.38% 2.08% 4.35%
% of Gross Profit 12.84% 11.96% 11.8%
Operating Expenses $24.00M $25.54M $23.17M
YoY Change 4.35% 10.25% 3.93%
Operating Profit $14.95M $15.42M $17.53M
YoY Change -20.37% -12.06% 31.94%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $200.0K $190.0K $158.0K
YoY Change 100.0% 20.25% 19.7%
Pretax Income $13.80M $15.61M $17.69M
YoY Change -26.98% -11.77% 31.82%
Income Tax $400.0K $4.572M $5.500M
% Of Pretax Income 2.9% 29.3% 31.09%
Net Earnings $13.33M $11.03M $12.19M
YoY Change 8.01% -9.47% 31.61%
Net Earnings / Revenue 17.11% 13.32% 14.97%
Basic Earnings Per Share $0.89 $0.75 $0.85
Diluted Earnings Per Share $0.86 $0.72 $0.82
COMMON SHARES
Basic Shares Outstanding 14.73M shares 14.68M shares 14.32M shares
Diluted Shares Outstanding 15.32M shares 14.83M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $296.9M $260.8M $204.3M
YoY Change 31.26% 27.66% 71.54%
Cash & Equivalents $226.0M $188.0M $127.5M
Short-Term Investments $70.90M $72.80M $76.80M
Other Short-Term Assets $11.70M $9.300M $10.10M
YoY Change 0.86% -7.92% -24.06%
Inventory $34.45M $34.15M $37.59M
Prepaid Expenses
Receivables $45.32M $51.79M $53.01M
Other Receivables $6.000M $7.700M $7.600M
Total Short-Term Assets $394.3M $363.8M $312.6M
YoY Change 21.13% 16.38% 31.75%
LONG-TERM ASSETS
Property, Plant & Equipment $87.86M $88.90M $83.64M
YoY Change 2.24% 6.28% -3.55%
Goodwill $1.478M $1.478M $1.478M
YoY Change 0.0% 0.0% 0.0%
Intangibles $8.490M $8.843M $10.42M
YoY Change -14.69% -15.16% -11.01%
Long-Term Investments
YoY Change
Other Assets $7.500M $5.600M $4.800M
YoY Change 33.93% 16.67% -23.81%
Total Long-Term Assets $105.3M $104.9M $100.3M
YoY Change 2.27% 4.55% -5.59%
TOTAL ASSETS
Total Short-Term Assets $394.3M $363.8M $312.6M
Total Long-Term Assets $105.3M $104.9M $100.3M
Total Assets $499.6M $468.7M $412.9M
YoY Change 16.6% 13.51% 20.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.34M $10.83M $12.17M
YoY Change 0.24% -11.0% 8.53%
Accrued Expenses $15.55M $16.24M $16.75M
YoY Change -12.68% -2.99% 30.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.89M $27.07M $28.91M
YoY Change -7.67% -6.36% 20.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.400M $3.300M $3.800M
YoY Change 33.33% -13.16% -15.56%
Total Long-Term Liabilities $4.400M $3.300M $3.800M
YoY Change 33.33% -13.16% -15.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.89M $27.07M $28.91M
Total Long-Term Liabilities $4.400M $3.300M $3.800M
Total Liabilities $34.90M $36.10M $39.90M
YoY Change -7.43% -9.52% 9.02%
SHAREHOLDERS EQUITY
Retained Earnings $382.6M $369.2M $329.8M
YoY Change 11.81% 11.95% 15.47%
Common Stock $80.01M $71.69M $63.74M
YoY Change 22.6% 12.47% 10.07%
Preferred Stock
YoY Change
Treasury Stock (at cost) $49.00K $8.948M $17.01M
YoY Change -99.68% -47.39% -53.7%
Treasury Stock Shares 1.000K shares 128.0K shares 276.0K shares
Shareholders Equity $464.7M $432.6M $373.0M
YoY Change
Total Liabilities & Shareholders Equity $499.6M $468.7M $412.9M
YoY Change 16.6% 13.51% 20.2%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $13.33M $11.03M $12.19M
YoY Change 8.01% -9.47% 31.61%
Depreciation, Depletion And Amortization $5.000M $4.900M $4.800M
YoY Change 6.38% 2.08% 4.35%
Cash From Operating Activities $23.50M $16.20M $9.400M
YoY Change -7.48% 72.34% -11.32%
INVESTING ACTIVITIES
Capital Expenditures -$3.400M -$3.700M -$5.400M
YoY Change -44.26% -31.48% 35.0%
Acquisitions
YoY Change
Other Investing Activities $1.600M $500.0K -$5.200M
YoY Change -153.33% -109.62% -74.0%
Cash From Investing Activities -$1.800M -$3.200M -$10.50M
YoY Change -80.43% -69.52% -56.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.40M 2.500M 6.200M
YoY Change 600.0% -59.68% -193.94%
NET CHANGE
Cash From Operating Activities 23.50M 16.20M 9.400M
Cash From Investing Activities -1.800M -3.200M -10.50M
Cash From Financing Activities 15.40M 2.500M 6.200M
Net Change In Cash 37.10M 15.50M 5.100M
YoY Change 101.63% 203.92% -125.37%
FREE CASH FLOW
Cash From Operating Activities $23.50M $16.20M $9.400M
Capital Expenditures -$3.400M -$3.700M -$5.400M
Free Cash Flow $26.90M $19.90M $14.80M
YoY Change -14.6% 34.46% 1.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2002000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10827000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11308000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51791000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49127000 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16244000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17810000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
112836000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
121249000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
20000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1429000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
573000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
63770000 USD
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
70205000 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1093000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
998000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q3 us-gaap Assets
Assets
468681000 USD
CY2012Q4 us-gaap Assets
Assets
428512000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
325503000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
363818000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
79259000 USD
CY2013Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
72815000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
273000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
288000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146900000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188030000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127524000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99590000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27934000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
41130000 USD
CY2012Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
226159000 USD
CY2013Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
260845000 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14458000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14727000 shares
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14257000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13925000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
29088000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
28658000 USD
CY2012Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2013Q3 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
119455000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
41860000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
40710000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
119988000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
3818000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4293000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5645000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5642000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5760000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5247000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14451000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14262000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note 2:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements:</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") number 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists &#8212; a consensus of the FASB Emerging Issues Task Force. ASU 2013-11 generally requires, with some exceptions, an entity to present its unrecognized tax benefits as it relates to its net operating loss carryforwards, similar tax losses, or tax credit carryforwards, as a reduction of deferred tax assets when settlement in this regard is available under the tax law of the applicable taxing jurisdiction as of the balance sheet reporting date.&#160;&#160;It is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013. Retrospective application is permitted. We do not anticipate a material impact on our financial position, results of operations or cash flows as a result of this change.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2013, the FASB issued ASU number 2013-02, Other Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income to improve the reporting of reclassifications out of accumulated other comprehensive income. ASU 2013-02 requires reporting the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income. It is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2012. The adoption of this ASU does not affect our consolidated financial statements, but could require additional disclosure if applicable in future periods.</font></div></div>
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1158000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-202000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.33
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4567000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4002000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
1478000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
40955000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-41000 USD
CY2013Q3 us-gaap Goodwill
Goodwill
1478000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
40695000 USD
us-gaap Gross Profit
GrossProfit
115787000 USD
us-gaap Gross Profit
GrossProfit
114742000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15606000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
38961000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
42897000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17688000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11875000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13959000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5500000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4572000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-943000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-790000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2538000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9790000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1236000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
682000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2974000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2471000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-792000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1572000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
460000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
505000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
640000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
536000 shares
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9952000 USD
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8843000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12512000 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11315000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
34153000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
36333000 USD
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4134000 USD
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18704000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
20808000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3013000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
2045000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1660000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
468681000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
428512000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27071000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29118000 USD
CY2013Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3290000 USD
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3290000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19436000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9007000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32231000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11279000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40931000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42244000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
570000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
158000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
438000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
190000 USD
us-gaap Operating Expenses
OperatingExpenses
77396000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
23165000 USD
us-gaap Operating Expenses
OperatingExpenses
72283000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
25539000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15416000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
38391000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17530000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
42459000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3223000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
713000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1737000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-132000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
450000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
255000 USD
CY2013Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
106000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
356000 USD
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
139000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
409000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
951000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
839000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
78534000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
71919000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15223000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13208000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5531000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7271000 USD
CY2012Q4 us-gaap Prepaid Taxes
PrepaidTaxes
2320000 USD
CY2013Q3 us-gaap Prepaid Taxes
PrepaidTaxes
7680000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
60452000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76681000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5016000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13214000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2457000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2220000 USD
us-gaap Profit Loss
ProfitLoss
28938000 USD
us-gaap Profit Loss
ProfitLoss
27086000 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
11034000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
12188000 USD
us-gaap Profit Loss
ProfitLoss
28938000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
210146000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
198773000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85937000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88897000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
40000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-143000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3140000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2988000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8410000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8949000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
369244000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
342158000 USD
CY2013Q3 us-gaap Revenues
Revenues
82815000 USD
us-gaap Revenues
Revenues
235775000 USD
us-gaap Revenues
Revenues
234197000 USD
CY2012Q3 us-gaap Revenues
Revenues
81405000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
82709000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
81266000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
235419000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
233788000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68447000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20177000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22399000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63873000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4361000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4133000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390857000 USD
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
432560000 USD
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
128000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
397000 shares
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
8948000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15128000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14613000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15139000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15324000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14826000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14613000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14684000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14153000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14603000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14321000 shares
CY2013Q3 icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2040
CY2013Q3 icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2013
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-2194000 USD
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-5094000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
124000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
291000 USD
icui Treasurystockacquiredinshareawardsswapforincometaxes
Treasurystockacquiredinshareawardsswapforincometaxes
43188 shares
icui Treasurystockacquiredshareawardsswapfortaxpayments
Treasurystockacquiredshareawardsswapfortaxpayments
0 USD
icui Treasurystockacquiredshareawardsswapfortaxpayments
Treasurystockacquiredshareawardsswapfortaxpayments
3033000 USD
icui Treasuystockacquiredfromshareawardsswap
Treasuystockacquiredfromshareawardsswap
94535 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000883984
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14734581 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE

Files In Submission

Name View Source Status
0000883984-13-000048-index-headers.html Edgar Link pending
0000883984-13-000048-index.html Edgar Link pending
0000883984-13-000048.txt Edgar Link pending
0000883984-13-000048-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
icui-20130930.xml Edgar Link completed
icui-20130930.xsd Edgar Link pending
icui-20130930_cal.xml Edgar Link unprocessable
icui-20130930_def.xml Edgar Link unprocessable
icui-20130930_lab.xml Edgar Link unprocessable
icui-20130930_pre.xml Edgar Link unprocessable
icui-ex311_20130930x10q.htm Edgar Link pending
icui-ex312_x20130930x10q.htm Edgar Link pending
icui-ex321_x20130930x10q.htm Edgar Link pending
icui0930201310-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending